AI MARKET SCANNING

Rhythm Pharmaceuticals Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.85%
MAX GAP RECORD -9.92%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $RYTM
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 04, 2026 Earnings Release 2026-08-04 (UNDETERMINED)
+0.00%
May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN)
+9.72%
Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN)
+4.14%
Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN)
-9.92%
Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN)
-3.38%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-1.02%
Feb 26, 2025 Earnings Release 2025-02-26 (UNDETERMINED)
+0.00%
Nov 05, 2024 Earnings Release 2024-11-05 (AFTER CLOSE)
+6.67%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.5%
Bullish Gaps (7)
Bearish Gaps (5)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $RYTM

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-28 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1616m +0.45%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗